NASDAQ: HYPD
Hyperion Defi Inc Stock

$2.08-0.26 (-11.11%)
Updated Nov 20, 2026
HYPD Price
$2.08
Fair Value Price
N/A
Market Cap
$32.22M
52 Week Low
$2.01
52 Week High
$4.99
P/E
-0.4x
P/B
0.23x
P/S
30.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.91M
Earnings
$79.71M
Gross Margin
84.1%
Operating Margin
4,224.08%
Profit Margin
1,913.4%
Debt to Equity
0.03
Operating Cash Flow
-$13M
Beta
1.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HYPD Overview

Hyperion DeFi, Inc. is a U.S. publicly listed company that is building a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain. The company's primary objective is to provide shareholders with streamlined access to the Hyperliquid ecosystem. Shareholders gain compounding exposure to HYPE through the token's native staking yield and additional revenues from its on-chain utility. The company also continues the development of its proprietary Optejet User Filled Device for ophthalmic applications, reflecting its transformation from its prior focus on ophthalmic technology.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HYPD's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
HYPD
Ranked
#68 of 447

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important HYPD news, forecast changes, insider trades & much more!

HYPD News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HYPD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HYPD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HYPD is good value based on its book value relative to its share price (0.23x), compared to the US Biotechnology industry average (4.78x)
P/B vs Industry Valuation
HYPD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HYPD due diligence checks available for Premium users.

Valuation

HYPD fair value

Fair Value of HYPD stock based on Discounted Cash Flow (DCF)

Price
$2.08
Fair Value
-$2.84
Undervalued by
173.22%
HYPD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HYPD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.4x
Industry
16.91x
Market
39.46x

HYPD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.23x
Industry
4.78x
HYPD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HYPD's financial health

Profit margin

Revenue
$810.4k
Net Income
$59.0M
Profit Margin
4,790.1%
HYPD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HYPD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$146.3M
Liabilities
$4.2M
Debt to equity
0.03
HYPD's short-term assets ($15.59M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HYPD's short-term assets ($15.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HYPD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HYPD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.7M
Investing
$8.5M
Financing
-$9.9M
HYPD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HYPD vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HYPDC$32.22M-11.11%-0.40x0.23x
FLNAD$32.22M+14.46%-0.74x0.56x
HYFTC$31.95M-14.29%-2.57x6.43x
ATNMC$33.01M-1.87%3.18x1.34x
VERUD$33.08M-8.06%-3.34x1.17x

Hyperion Defi Stock FAQ

What is Hyperion Defi's quote symbol?

(NASDAQ: HYPD) Hyperion Defi trades on the NASDAQ under the ticker symbol HYPD. Hyperion Defi stock quotes can also be displayed as NASDAQ: HYPD.

If you're new to stock investing, here's how to buy Hyperion Defi stock.

What is the 52 week high and low for Hyperion Defi (NASDAQ: HYPD)?

(NASDAQ: HYPD) Hyperion Defi's 52-week high was $4.99, and its 52-week low was $2.01. It is currently -58.32% from its 52-week high and 3.48% from its 52-week low.

How much is Hyperion Defi stock worth today?

(NASDAQ: HYPD) Hyperion Defi currently has 15,488,133 outstanding shares. With Hyperion Defi stock trading at $2.08 per share, the total value of Hyperion Defi stock (market capitalization) is $32.22M.

Hyperion Defi stock was originally listed at a price of $793.60 in Jan 25, 2018. If you had invested in Hyperion Defi stock at $793.60, your return over the last 8 years would have been -99.74%, for an annualized return of -52.43% (not including any dividends or dividend reinvestments).

How much is Hyperion Defi's stock price per share?

(NASDAQ: HYPD) Hyperion Defi stock price per share is $2.08 today (as of Nov 20, 2026).

What is Hyperion Defi's Market Cap?

(NASDAQ: HYPD) Hyperion Defi's market cap is $32.22M, as of Nov 22, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hyperion Defi's market cap is calculated by multiplying HYPD's current stock price of $2.08 by HYPD's total outstanding shares of 15,488,133.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.